Diversified Healthcare Trust DHC.OQ DHC.O is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2024
The Newton Massachusetts-based company is expected to report a 7.1% increase in revenue to $370.648 million from $346.03 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Diversified Healthcare Trust is for a loss of 28 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Diversified Healthcare Trust is $3.50, above its last closing price of $2.62.
This summary was machine generated May 4 at 02:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)